导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 9.56% | 309/1050 |
| 近一周 | -2.33% | 576/1104 |
| 近一月 | -3.36% | 456/1102 |
| 近一季 | -8.14% | 745/1092 |
| 近半年 | 1.32% | 403/1070 |
| 近一年 | 10.27% | 350/1018 |
| 近两年 | 78.82% | 295/926 |
| 近三年 | 70.74% | 145/833 |
| 成立以来 | 66.68% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.78% 274/1070 |
36.11% 281/1101 |
- - |
- - |
| 2025 | 47.70% 219/1065 |
6.12% 331/1014 |
8.07% 155/1038 |
32.39% 330/1050 |
-2.73% 596/1065 |
| 2024 | 9.33% 304/1011 |
6.65% 67/960 |
3.50% 142/983 |
2.09% 934/991 |
-2.97% 534/1011 |
| 2023 | -14.56% 503/952 |
-0.84% 659/880 |
-3.94% 445/895 |
-6.57% 397/915 |
-3.99% 407/952 |
| 2022 | -31.12% 652/867 |
-17.71% 409/773 |
7.67% 365/806 |
-11.21% 315/845 |
-12.45% 817/867 |
| 2021 | -7.44% 456/740 |
-7.46% 435/580 |
18.97% 171/659 |
-10.52% 523/704 |
-6.04% 616/740 |
| 2020 | 74.53% 119/554 |
-4.85% 284/419 |
30.95% 115/466 |
17.15% 98/517 |
19.57% 124/554 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 南方ESG股票A VS. 东吴新产业精选股票A(580008) |